Dr. Colin C. Pritchard's Profile

Dr. Colin C. Pritchard

Department of Laboratory Medicine
Dr. Colin C. Pritchard, Associate Professor in the Department of Laboratory Medicine, and Associate Director of the Genetics and Solid Tumors Laboratory at the University of Washington School of Medicine the first author of the study

Genetic Screening for Inherited Mutations Could Benefit Men With Metastatic Prostate Cancer

  • Prostate cancer is one of the most common types of cancer in men
  • Inherited mutations are tied to advanced prostate cancer risk
  • Screening for mutations in DNA-repair genes and BRAC1 and BRAC2 genes can benefit men with metastatic prostate cancer.

Genetic screening could help men with prostate cancer find better treatment options. Men with advanced prostate cancer could benefit from screening for mutations in DNA-repair genes including the breast cancer genes (BRAC1 and BRAC2). The study published in The New England Journal of Medicine was led by researchers at Fred Hutchinson Cancer Research Center and the University of Washington.

'DNA repair genes' help maintain the integrity of the genetic code of the cell. If there is a mutation in the DNA repair genes, the DNA is less likely to repaired when there is an aberration in its code thereby increasing the cancer risk of the cell. ...

Read More

Other Interviews

Kalki Subramaniam Mr. S.K. Dogra Dr. Raj B Singh, MD, FRCP, FCCP Dr. Abhishek Srivastava Dr. Georgi Abraham Dr. Rekha Ramachandran Dr. S. Suresh Shefali Chhachhi Dr. Vivek Khemka, MD, Dr. Davinder Gill Dr. K. Jayanth Murali, IPS., Padmini Ramesh Dr. Tirath Das Dogra Dr. Sumana Navin Dr. Ambika Kameshwar, Ph.D. PDF Dr Dharini Krishnan Mr. Sathyanarayanan Dr. M.S. Ranjit, DCH, MD (Pediatrics) Dr Duru Shah Dr. Dharini Krishnan, Ph.D, Dr.Makani Hemadri Dr. Muffazal Lakdawala Dr. Dolly Khanna R. Lavanya Ebenezer Joseph Meena Dhadha Dr. Neha Gupta Dr. Suniti Solomon Kanchana Dr. Johan Lundstrom